Din‐Li Tsan

608 total citations
20 papers, 475 citations indexed

About

Din‐Li Tsan is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Din‐Li Tsan has authored 20 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Otorhinolaryngology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Din‐Li Tsan's work include Head and Neck Cancer Studies (9 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Medical Imaging Techniques and Applications (3 papers). Din‐Li Tsan is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Medical Imaging Techniques and Applications (3 papers). Din‐Li Tsan collaborates with scholars based in Taiwan, United States and United Kingdom. Din‐Li Tsan's co-authors include Tzu‐Chen Yen, Yu-Hua Fang, Shu‐Hang Ng, Joseph Tung‐Chieh Chang, Nai-Ming Cheng, Chun-Ta Liao, Hung‐Ming Wang, Hung‐Ming Wang, Chien-Yu Lin and Ching‐Han Hsu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Cancer.

In The Last Decade

Din‐Li Tsan

17 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Din‐Li Tsan Taiwan 9 310 216 182 141 88 20 475
Hung‐Ming Wang Taiwan 9 264 0.9× 213 1.0× 122 0.7× 139 1.0× 155 1.8× 10 499
Roland M. Martens Netherlands 13 373 1.2× 196 0.9× 83 0.5× 66 0.5× 63 0.7× 24 464
Nai-Ming Cheng Taiwan 9 329 1.1× 108 0.5× 124 0.7× 68 0.5× 53 0.6× 10 378
Hon Biu Chan Canada 8 180 0.6× 143 0.7× 113 0.6× 122 0.9× 117 1.3× 11 335
Giovanna Sartor Italy 10 275 0.9× 114 0.5× 240 1.3× 75 0.5× 87 1.0× 22 464
Gokoulakrichenane Loganadane France 10 147 0.5× 101 0.5× 164 0.9× 76 0.5× 126 1.4× 39 374
N. Caria United States 10 130 0.4× 236 1.1× 212 1.2× 155 1.1× 145 1.6× 26 466
Tom Vercauteren Belgium 15 360 1.2× 162 0.8× 273 1.5× 111 0.8× 62 0.7× 38 696
Norihiro Aibe Japan 12 115 0.4× 83 0.4× 309 1.7× 178 1.3× 94 1.1× 65 513
David J. Noble United Kingdom 12 238 0.8× 48 0.2× 168 0.9× 73 0.5× 29 0.3× 26 427

Countries citing papers authored by Din‐Li Tsan

Since Specialization
Citations

This map shows the geographic impact of Din‐Li Tsan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Din‐Li Tsan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Din‐Li Tsan more than expected).

Fields of papers citing papers by Din‐Li Tsan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Din‐Li Tsan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Din‐Li Tsan. The network helps show where Din‐Li Tsan may publish in the future.

Co-authorship network of co-authors of Din‐Li Tsan

This figure shows the co-authorship network connecting the top 25 collaborators of Din‐Li Tsan. A scholar is included among the top collaborators of Din‐Li Tsan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Din‐Li Tsan. Din‐Li Tsan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Teng, Wei, Eric Yi-Liang Shen, Bing‐Shen Huang, et al.. (2024). Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma. The Oncologist. 29(7). e922–e931. 6 indexed citations
4.
Cheng, Nai‐Ming, Chien‐Yu Lin, Chun‐Ta Liao, et al.. (2023). The added values of 18F-FDG PET/CT in differentiating cancer recurrence and osteoradionecrosis of mandible in patients with treated oral squamous cell carcinoma. EJNMMI Research. 13(1). 25–25. 2 indexed citations
5.
Lin, Shinn‐Yn, Din‐Li Tsan, Chi‐Cheng Chuang, et al.. (2022). Oncological Outcomes After Hippocampus-Sparing Whole-Brain Radiotherapy in Cancer Patients With Newly Diagnosed Brain Oligometastases: A Single-Arm Prospective Observational Cohort Study in Taiwan. Frontiers in Oncology. 11. 784635–784635. 3 indexed citations
6.
Shen, Eric Yi-Liang, Tsung‐Min Hung, Din‐Li Tsan, et al.. (2022). Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating Epstein–Barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma. Radiotherapy and Oncology. 177. 1–8. 7 indexed citations
7.
8.
Wang, Cheng‐Hsu, K. S. Clifford Chao, Ping‐Tsung Chen, et al.. (2022). PEP503 (NBTXR3), a radioenhancer, in combination with concurrent chemoradiation (CCRT) in locally advanced or recurrent head and neck squamous cell carcinoma (HNSCC): Dose-finding of a phase 1b/2 trial.. Journal of Clinical Oncology. 40(16_suppl). e18041–e18041. 2 indexed citations
9.
Shen, Eric Yi-Liang, et al.. (2021). Treatment-related sequelae in Hodgkin’s lymphoma after mediastinal irradiation. International Journal of Hematology. 115(3). 363–370.
12.
Wy, Chen, Lan‐Yan Yang, Din‐Li Tsan, et al.. (2019). Optimal Timing for Postsurgical Adjuvant Therapy in Patients with Gastric Cancer: A Propensity Score Matching Study. Journal of Cancer. 10(2). 332–340. 15 indexed citations
14.
Cheng, Nai-Ming, Yu-Hua Fang, Din‐Li Tsan, Ching‐Han Hsu, & Tzu‐Chen Yen. (2016). Respiration-Averaged CT for Attenuation Correction of PET Images – Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients. PLoS ONE. 11(3). e0150509–e0150509. 21 indexed citations
15.
Wang, Hung‐Ming, Nai‐Ming Cheng, Li‐Yu Lee, et al.. (2015). Heterogeneity of 18F‐FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma. International Journal of Cancer. 138(3). 731–738. 19 indexed citations
16.
Cheng, Nai-Ming, Yu-Hua Fang, Li‐Yu Lee, et al.. (2014). Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 42(3). 419–428. 103 indexed citations
17.
Cheng, Nai-Ming, Yu-Hua Fang, Joseph Tung‐Chieh Chang, et al.. (2013). Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma. Journal of Nuclear Medicine. 54(10). 1703–1709. 124 indexed citations
19.
Cheng, Nai‐Ming, Joseph Tung‐Chieh Chang, Chung‐Guei Huang, et al.. (2012). Prognostic value of pretreatment 18F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 39(11). 1673–1684. 43 indexed citations
20.
Tsan, Din‐Li, Chien-Yu Lin, Chung‐Jan Kang, et al.. (2012). The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity. Radiation Oncology. 7(1). 215–215. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026